Acetaminophen
- Product NDC
- 84549-100
- Requested package NDC
- 84549-100-90
- 11-digit product format
- 845490100
- Labeler code
- 84549
- Product ID
- 84549-100_3f7a6fdc-6e37-dc3e-e063-6394a90a067d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- ProPharma Distribution
- Application
- NDA204957
- Marketing category
- NDA
- Marketing start
- 2021-02-18
- Substance
- ACETAMINOPHEN
- Active strength
- 10 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204957-001 | ACETAMINOPHEN | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2021-02-18 |
| N204957-002 | ACETAMINOPHEN | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2021-02-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N204957-001 | AP |
| N204957-002 | AP2 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2021-02-18 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2021-02-18 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2021-02-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2021-02-18 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2021-02-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2021-02-18 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2021-02-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2021-02-18 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2021-02-18 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2021-02-18 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204957-001 | ACETAMINOPHEN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204957-002 | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2021-02-18 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N204957-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204957-002 | AP2 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N204957-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204957-002 | AP2 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N204957-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204957-002 | AP2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204957-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204957-002 | AP2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N204957-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204957-002 | AP2 | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N204957-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N204957-002 | AP2 | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetaminophen
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 10 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 483017 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3f7a6fdc-6e36-dc3e-e063-6394a90a067d | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84549-100-90 | Acetaminophen | 100 mL in 1 CONTAINER | INJECTION | 100 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | ProPharma Distribution | 3f7a6fdc-6e36-dc3e-e063-6394a90a067d | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | 204957 NDA204957 84549-100-90 84549-100 84549010090 |
| Acetaminophen | ACETAMINOPHEN | B. Braun Medical Inc. | 9744d804-2857-47ef-a27a-bca27db9394c | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | 204957 NDA204957 |
| Acetaminophen | ACETAMINOPHEN | B. Braun Medical Inc. | 6d763554-913d-4bed-9efd-b9c9b936a2f4 | 2023-05-18 | Boxed warning, Warnings, Adverse reactions | 204957 NDA204957 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 483017 | acetaminophen 1000 MG in 100 ML Injection | PSN | 3f7a6fdc-6e36-dc3e-e063-6394a90a067d | 1 |
| 483017 | 100 ML acetaminophen 10 MG/ML Injection | SCD | 3f7a6fdc-6e36-dc3e-e063-6394a90a067d | 1 |
| 483017 | 100 ML APAP 10 MG/ML Injection | SY | 3f7a6fdc-6e36-dc3e-e063-6394a90a067d | 1 |
| 483017 | acetaminophen 1000 MG per 100 ML Injection | SY | 3f7a6fdc-6e36-dc3e-e063-6394a90a067d | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 84549-100-90 | 84549010090 | 100 mL in 1 CONTAINER (84549-100-90) | 100 ml | 2025-09-23 | No | No | Current |